Authors: Rege, K Swansbury, GJ Atra, AA Horton, C Min, T Dainton, MG Matutes, E Durosinmi, M Treleaven, JG Powles, RL Catovsky, D

Citation: K. Rege et al., Disease features in acute myeloid leukemia with t(8;21)(q22;g22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival, LEUK LYMPH, 40(1-2), 2000, pp. 67-77

Authors: Saso, R Kulkarni, S Mitchell, P Treleaven, J Swansbury, GJ Mehta, J Powles, R Ashley, S Kuan, A Powles, T

Citation: R. Saso et al., Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma, BR J CANC, 83(1), 2000, pp. 91-94

Authors: Mehta, J Powles, R Treleaven, J Swansbury, GJ Kulkarni, S Saso, R Min, T Singhal, S

Citation: J. Mehta et al., The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy, LEUK LYMPH, 34(5-6), 1999, pp. 553-560

Authors: Bueno, JL Watson, A Dainton, MG Hughes, DM Killick, S Treleaven, JG Swansbury, GJ

Citation: Jl. Bueno et al., Monosomy X as the sole cytogenetic abnormality in acute lymphoblastic leukemia: A report of two new patients, LEUK LYMPH, 32(3-4), 1999, pp. 381-384

Authors: Dearden, CE Matutes, E Hilditch, BL Swansbury, GJ Catovsky, D

Citation: Ce. Dearden et al., Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine, BR J HAEM, 106(2), 1999, pp. 515-519